GSK Hit With Suit Over Avodart's Prostate Cancer Risks
GlaxoSmithKline PLC was hit with a product liability suit in Pennsylvania state court Wednesday claiming the pharmaceutical giant concealed or downplayed the potentially life-threatening side effects of its prostate drug Avodart,...To view the full article, register now.
Already a subscriber? Click here to view full article